TPP Would Create ‘Damaging Monopolies,’ Hurt Health System

Washington Post: Letter to the Editor: The Trans-Pacific Partnership would worsen health crises
Rohit Malpani, director of policy and analysis for Médecins Sans Frontières’s Access Campaign

“The April 25 editorial ‘A healthy agreement’ suggested the [Trans-Pacific Partnership (TPP)] won’t significantly restrict access to medicines, including in developing countries. [However, some] countries … have seen dramatically higher prices for medicines under TPP-like rules. … The TPP introduces damaging monopolies. Yet even the status quo is a crisis. Too many patients worldwide cannot afford treatment. The patent system doesn’t address many health needs, including antibiotic resistance. Countries should reject the TPP. Doubling down on the current system isn’t just the wrong prescription; it’s also a deadly one” (4/28).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.